Decreasing clostridium difficile infections in surgery: Impact of a practice bundle incorporating a resident rounding protocol

Connecticut Medicine

Volumn 77, Issue 2, 2013, Pages 69-75

  Bishop, Jennifer ^a   Parry, Michael F ^a   Hall, Timothy ^b  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b Stamford Hospital Affiliate of Columbia University ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT;

ARTICLE; CLOSTRIDIUM DIFFICILE; COMPARATIVE STUDY; CROSS INFECTION; HAND WASHING; HUMAN; INCIDENCE; INFECTION CONTROL; ISOLATION AND PURIFICATION; METHODOLOGY; MICROBIOLOGY; PRACTICE GUIDELINE; PROSPECTIVE STUDY; PSEUDOMEMBRANOUS COLITIS; UNITED STATES;

ANTI-BACTERIAL AGENTS; CLOSTRIDIUM DIFFICILE; CROSS INFECTION; ENTEROCOLITIS, PSEUDOMEMBRANOUS; HAND DISINFECTION; HUMANS; INCIDENCE; INFECTION CONTROL; PRACTICE GUIDELINES AS TOPIC; PROSPECTIVE STUDIES; UNITED STATES;

EID: 84874644397     PISSN: 00106178     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Muto CA, Blank MK, Marsh JW, et al: Control of an outbreak of infection with hypervirulent Clostridium difficile BI strain in a university hospital using a comprehensive bundle approach. Clin Infect Dis 2007; 45:1266-1273. (Pubitemid 351411898)
2. Carling PC, Parry MM, Rupp ME, et al: for the Healthcare Environmental Hygiene Study Group. Improving cleaning of the environment surrounding patients in 36 acute care hospitals. Inf Control Hosp Epidemiol 2008; 29: 1035-1041.
3. Bratzler DW, Houck PM, Richards C, et al: Use of Antimicrobial Prophylaxis for major surgery; Baseline results from the National Surgical Infection Prevention Project. Arcb Surg 2005; 140:174-182. (Pubitemid 40229109)
4. Siegel JD, Rhinehart E, Jackson M, Chiarello L, and the Healthcare Infection Control Practices Advisory Committee, 2007: Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Healthcare Settings Am J Infect Control 2007; 35: S65-164.
5. O'Brien JA, Lahue BJ, Caro JJ, Davidson DM:The emerging infectious challenge of Clostridium difficile-associated disease in Massachusetts hospitals: clinical and economic consequences. Infect Control Hosp Epidemiol 2007; 28:1219-1227. (Pubitemid 47596558)
6. Redelings MD, Sorvillo F, Mascola L: Increase in Clostridium difficile-related mortality rates, United States, 1999-2004. Emerg Infect Dis 2007 Sep; 13: 1417.
7. Miller BA, Chen LF, Sexton DJ, Anderson DJ: Comparison of the burdens of hospital-onset, healthcare facility-associated Clostridium difficile Infection and fo healthcare-associated infection due to methicillin-resistant Staphylococcus aureus in community hospitals. Infect Control Hosp Epidemiol 2011; 32: 387-90
8. Cohen, SH; Gerding, DN; Johnson S; Kelly CP et al: Clinical Practice Guidelines for Clostridium difficile Infection in Adults: 2010: Update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA) Infect Control Hosp Epidemiol 2010; 31: 431-455.
9. Dallai RM, Harbrecht BG, Boujoukas AF, Sirio CA et al: Fulminant Costtridium Difficile: An underappreciated and increasing cause of death and complications. Ann Surg 2002; 235:363-72. (Pubitemid 34183887)
10. Cohen, SH; Gerding, DN; Johnson S, Kelly CP, Loo VG, McDonald LC, PepinJ, WilcoxMH: Clinical Practice Guidelines for Clostridium difficile Infection in Adults: 2010 Update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA) Infect Control Hosp Epidemiol 2010; 31: 431-455.
11. Zerey M, Paton BL, Lincourt AE, Gersin KS et al: The burden of Clostridium difficile in surgical patients in the United States. Surg Infect (Larchmt). 2007; 8: 557-66.
12. Privitera G, Scarpellini P, Ortisi G, Nicastro G et al: Prospective study of Clostridium difficile intestinal colonization and disease following single dose antibiotic prophylaxis in surgery. Antimicrob Agents Chemother 1991; 35: 208-210.
13. Yee J, Dixon CM, McLean AP, Meakins JL: Clostridium difficile in a department of surgery. The significance of prophylactic antibiotics. Arch Surg 1991; 126: 241-246.
14. Cunningham R, Dial S: Is over-use of proton pump inhibitors fuelling the current epidemic of Clostridium difficile-associated diarrhea? J Hosp Infect 2008; 70: 1-6.
15. Dial S, DelaneyJA, Barkun AN, Suissa S: Use of gastric acidsuppressive agents and the risk of community-acquired Clostridium difficile-asscociated disease. JAMA2005 21;294:2989-95. (Pubitemid 41817660)
16. Vesta KS, Wells PG, Gentry CA, Stipek WJ: Specific risk factors for Clostridium difficile-associated diarrhea: a prospective, multicenter, case control evaluation. Am J Infect Control 2005; 33:469-72. (Pubitemid 41433330)
17. Howell MD, Novack V, Grgurich P, Soulliard D et al: Iatrogenic gastric acid suppression and the risk of nosocomial Clostridium difficile infection. Arch Intern Med 2010; 170: 784-90.
18. Hauben M, Horn S, Reich L, Younus M: Association between gastric acid suppressants and Clostridium difficile colitis and community-acquired pneumonia: Analysis using pharmacovigilance tools. Int J Infect Dis 2007; 11:417-22. (Pubitemid 47239451)
19. Aseeri M, Schroeder T, Kramer J, Zackula R; Gastric acid suppression by proton pump inhibitors as a risk factor for Clostridium difficile-associated diarrhea in hospitalized patients. Am J Gastroenterol 2008; 103: 2308-13.
20. Cunningham R, Dale B, Undy B, Gaunt N: Proton pump inhibitors as a risk factor for Clostridium difficile diarrhea. J Hosp Infect 2003; 54:243-5. (Pubitemid 38002001)
21. Cadle RM, Mansouri MD, Logan N, Kudva DR, Musher DM: Association of proton-pump inhibitors with outcomes in Clostridium difficile colitis. AmJ Health Syst Pharm 2007; 64:2359-63. (Pubitemid 350174708)
22. Guide to the Elimination of Clostridium difficile in healthcare Settings. 2008 APIC website, www.apic.org.
23. Carling P, Fung T, Killion A, Terrin N, and Barza M: Favorable impact of a multidisciplinary antiobiotic management program conducted during 7 years. Infection Control and Hospital Epidemiology 2003; 24: 699-706. (Pubitemid 37221343)
24. Valiquette L, Cossette B, Garant MP, Diab H, PepinJ: Impact of a reduction in the use of high-risk antibiotics on the course of an epidemic of Clostridium difficile-associated disease caused by the hypervirulent NAP1/027 strain. CID 2007; 45 (Suppl 2):S112-S121. (Pubitemid 47328625)
25. Owens RC, Donskey CJ, Gaynes RP, Loo VG, Muto CA: Antimicrobial associated risk factors for Clostridium difficile infection. Clin Infectious Dis 2008; 46:S19-S31. (Pubitemid 351323662)
26. Fowler S, Webber A, Cooper BS, Phimister A et al: Successful use of feedback to improve antibiotic prescribing and reduce Clostridium difficile infection: A controlled interrupted time series. Journal of Antimicrobial Chemotherapy (2007), 59:990-995. (Pubitemid 47073372)
27. Pear SM, Williamson TH, Bettin KM, Gerding DN, Galgiani JN: Decrease in nosocomial Clostridium difficile -associated by restricting clindamycin use. Ann Intern Ann Intern Med 1994; 121: 307.
28. Siegel JD, Rhinehart E, Jackson M, Chiarello L, and the Healthcare Infection Control Practices Advisory Committee 2007: Guideline for isolation precautions: Preventing transmission of infectious agents in healthcare settings. Am J Infect Control 2007; 35 ( 10 Suppl 2): S65-164.
29. Abbett SK Yokeo DE, Lipsitz SR, Bader AM, et al: Proposed checklist of hospital interventions to decrease the incidence of health associated Clostridium difficile infection. Infect Contol Hosp Epidemiol 2009; 30: 1062-9.
30. Muto CA, Blank MK, Marsh JW, Vergis EN, et al: Control of an outbreak of an infection with the hypervirulent Clostridium difficile BI strain in a university hospital using a comprehensive "bundle" approach. CID 2007, 45: 1266-127
31. Strymish J, Brecher S, Tibert C, Hylander D, Gupta K: Multiple interventions are necessary to decrease C difficile infections. SHEA 2011 abstract 188.